Tag: bespoke

Research Impact: Custom Biocytogen mouse models used to identify critical mediator of inflammation-driven metastases

September 7, 2022

By John Charpentier, Ph.D. September 7, 2022 While metastases are ultimately responsible for the large majority of cancer deaths, most oncology drugs in development target primary tumors, and few specifically prevent metastasis. Although surgical resection of solid tumors is an effective early treatment intervention, the resulting inflammation can promote metastasis by increasing adhesion of circulating […]

Read More

Back to top